Loading...
OTCM
CNVIF
Market cap19mUSD
Jul 09, Last price  
0.17USD
1D
4.85%
1Q
-36.47%
Jan 2017
-29.35%
IPO
-45.31%
Name

Titan Medical Inc

Chart & Performance

D1W1MN
OTCM:CNVIF chart
P/E
P/S
4.07
EPS
Div Yield, %
Shrs. gr., 5y
-3.01%
Rev. gr., 5y
-25.93%
Revenues
5m
+117.30%
000000000000021,056,53319,916,201017,955,3492,161,0004,695,929
Net income
-11m
L-75.78%
-331,784-2,269,656-712,813-3,785,093-15,838,476-7,790,744-8,794,116-12,825,565-38,142,072-23,042,996-34,794,880-21,484,733-42,881,355-24,184,000-14,727,264-40,856,3716,953,000-43,615,000-10,561,465
CFO
-13m
L-35.87%
-253,988-1,939,911-415,166-3,111,340-14,838,410-7,756,603-7,717,750-12,277,264-31,610,929-34,775,647-19,088,860-41,396,777-45,961,000-889,761-36,294,807-26,485,2854,681,000-20,147,000-12,921,270

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
IPO date
Apr 28, 2008
Employees
33
Domiciled in
CA
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT